ArticleHuman vaccines & immunotherapeutics2022

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years.

Ivette Maldonado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.